DANIEL PIOTTER: Open Payments
NPI 1225490600 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 78 payments from 16 companies in 2025. Trend: 2023 $353 · 2024 $858 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $229 |
| Axsome Therapeutics, Inc. | 13 | $204 |
| Alkermes, Inc. | 12 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $155 |
| BioWound Solutions, Inc. | 1 | $128 |
| Vanda Pharmaceuticals Inc. | 2 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Novo Nordisk Inc | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
Products named: VRAYLAR, Auvelity, ARISTADA, Kerendia, bio-ConneKt, FANAPT, CAPLYTA, REXULTI.
Industry payments across LA — which companies pay providers there.
